TREATMENT WITH HOMODIMERIC INTERLEUKIN-12 (IL-12) P40 PROTECTS MICE FROM IL-12-DEPENDENT SHOCK BUT NOT FROM TUMOR-NECROSIS-FACTOR ALPHA-DEPENDENT SHOCK

Citation
F. Mattner et al., TREATMENT WITH HOMODIMERIC INTERLEUKIN-12 (IL-12) P40 PROTECTS MICE FROM IL-12-DEPENDENT SHOCK BUT NOT FROM TUMOR-NECROSIS-FACTOR ALPHA-DEPENDENT SHOCK, Infection and immunity, 65(11), 1997, pp. 4734-4737
Citations number
28
Categorie Soggetti
Immunology,"Infectious Diseases
Journal title
ISSN journal
00199567
Volume
65
Issue
11
Year of publication
1997
Pages
4734 - 4737
Database
ISI
SICI code
0019-9567(1997)65:11<4734:TWHI(P>2.0.ZU;2-Z
Abstract
The role of interleukin-12 (IL-12) was investigated in different shock models using anti-IL-12 reagents. IL-12 is composed of two disulfide- bonded subunits, p35 and p40. The IL-12 p40 homodimer (p40)(2) has bee n shown to be a potent IL-12 antagonist in vitro. We investigated its in vivo inhibitory capacity in different shock models of mice. We coul d demonstrate that (p40)(2) is able to protect mice from septic shock in primarily IL-12-dependent models such as the Shwartzman reaction an d lipopolysaccharide (LPS)-induced shock, whereas (p40)(2) has no effe ct in the tumor necrosis factor alpha-dependent LPS/D-GaIN shock model . In IL-12-dependent shock models, (p40)(2) inhibits IL-12-induced gam ma interferon production and thereby interferes with the cascade of cy tokine release, finally leading to death.